Understanding Hair Loss: Key Causes and Effective Treatment Paths
Genetics is a major cause of hereditary hair loss. This type of hair loss is called androgenetic alopecia or male/female pattern baldness. In men, it presents as thinning hair on the frontal scalp area and vertex (top of the head). In women, it may present as generalized thinning over the top of the scalp. About 50% of men begin losing their hair by age 50. Genetics determine hair follicle sensitivity to dihydrotestosterone (DHT), a hormone derived from testosterone. DHT binding to hair follicles reduces their size and life span over time.
Other medical conditions like thyroid disorders, iron deficiency anemia, chronic illnesses, autoimmune diseases and infections can also trigger temporary or permanent hair shedding. Some treatments like Hair Loss Treatment , chemotherapy, radiation therapy, medications containing isotretinoin, anticoagulants, antidepressants and blood thinners may lead to telogen effluvium - temporary shedding of hair within a few months of starting or changing the treatment regimen.
Hair Loss Treatment-https://www.coherentmarketinsights.com/market-insight/hair-loss-treatment-market-4374
#HairLossTreatment,
#MalePatternBaldness,
#DHT,
#AndrogenicAlopecia,
#Finasteride,
#Minoxidil,
#Coherent Market Insights
Genetics is a major cause of hereditary hair loss. This type of hair loss is called androgenetic alopecia or male/female pattern baldness. In men, it presents as thinning hair on the frontal scalp area and vertex (top of the head). In women, it may present as generalized thinning over the top of the scalp. About 50% of men begin losing their hair by age 50. Genetics determine hair follicle sensitivity to dihydrotestosterone (DHT), a hormone derived from testosterone. DHT binding to hair follicles reduces their size and life span over time.
Other medical conditions like thyroid disorders, iron deficiency anemia, chronic illnesses, autoimmune diseases and infections can also trigger temporary or permanent hair shedding. Some treatments like Hair Loss Treatment , chemotherapy, radiation therapy, medications containing isotretinoin, anticoagulants, antidepressants and blood thinners may lead to telogen effluvium - temporary shedding of hair within a few months of starting or changing the treatment regimen.
Hair Loss Treatment-https://www.coherentmarketinsights.com/market-insight/hair-loss-treatment-market-4374
#HairLossTreatment,
#MalePatternBaldness,
#DHT,
#AndrogenicAlopecia,
#Finasteride,
#Minoxidil,
#Coherent Market Insights
Understanding Hair Loss: Key Causes and Effective Treatment Paths
Genetics is a major cause of hereditary hair loss. This type of hair loss is called androgenetic alopecia or male/female pattern baldness. In men, it presents as thinning hair on the frontal scalp area and vertex (top of the head). In women, it may present as generalized thinning over the top of the scalp. About 50% of men begin losing their hair by age 50. Genetics determine hair follicle sensitivity to dihydrotestosterone (DHT), a hormone derived from testosterone. DHT binding to hair follicles reduces their size and life span over time.
Other medical conditions like thyroid disorders, iron deficiency anemia, chronic illnesses, autoimmune diseases and infections can also trigger temporary or permanent hair shedding. Some treatments like Hair Loss Treatment , chemotherapy, radiation therapy, medications containing isotretinoin, anticoagulants, antidepressants and blood thinners may lead to telogen effluvium - temporary shedding of hair within a few months of starting or changing the treatment regimen.
Hair Loss Treatment-https://www.coherentmarketinsights.com/market-insight/hair-loss-treatment-market-4374
#HairLossTreatment,
#MalePatternBaldness,
#DHT,
#AndrogenicAlopecia,
#Finasteride,
#Minoxidil,
#Coherent Market Insights
0 Comments
0 Shares
14 Views